APA (7th ed.) Citation

M, R., F, C., F, B., M, G., M, P., L, C., . . . M, M. (2023). Repurposing pentamidine using hyaluronic acid-based nanocarriers for skeletal muscle treatment in myotonic dystrophy. Nanomedicine : nanotechnology, biology, and medicine, 47, 102623. https://doi.org/10.1016/j.nano.2022.102623

Chicago Style (17th ed.) Citation

M, Repellin, et al. "Repurposing Pentamidine Using Hyaluronic Acid-based Nanocarriers for Skeletal Muscle Treatment in Myotonic Dystrophy." Nanomedicine : Nanotechnology, Biology, and Medicine 47 (2023): 102623. https://doi.org/10.1016/j.nano.2022.102623.

MLA (9th ed.) Citation

M, Repellin, et al. "Repurposing Pentamidine Using Hyaluronic Acid-based Nanocarriers for Skeletal Muscle Treatment in Myotonic Dystrophy." Nanomedicine : Nanotechnology, Biology, and Medicine, vol. 47, 2023, p. 102623, https://doi.org/10.1016/j.nano.2022.102623.